Read article – An opinion piece by Paul Manganiello, active emeritus professor of obstetrics and gynecology, in which he discusses how drug addiction and gun violence are related to the immigration crisis.

Read article – Quotes Karissa LeClair, Geisel ’20, who worked with fellow Geisel student Nicholas Valentini ’13, Geisel ’20, and Dartmouth-Hitchcock’s Lyme clinic and Upper Valley Ambulance to create a pilot project in which paramedics use downtime between emergency calls to visit patients in Orford and Piermont.

Read article – Quotes Timothy Fisher, assistant professor of obstetrics and gynecology, about the state of midwifery in the U.S. “The midwifery model of care emphasizes normalcy and wellness. It empowers women and gives them greater ownership of their health, their pregnancy, and the outcomes of that pregnancy based on choices that they’re able to make,” says Fisher. “Unfortunately, the medical model of prenatal care can take some of that ownership away, in a way that can ultimately be detrimental for some people.”

Read article – Quotes Michael Whitfield, interim chair and professor of biomedical data science, and Jennifer Franks, a PhD student in the quantitative biomedical sciences program, about a study they conducted that may help identify scleroderma patients who could benefit most from stem cell transplants.

Read article – Quotes David Bzik, professor of microbiology and immunology, in a news brief about research he is leading to develop a cancer vaccine from the parasite Toxoplasma gondii.

Read article – As guests on a podcast produced by HealthNewsReview, Lisa Schwartz and Steven Woloshin, both professors of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, discuss the pollution of healthcare information. (Schwartz and Woloshin’s comments begin at approximately 2:35.)

Read article – An opinion piece by John Turco, professor of medicine, in which he discusses how the Trump administration’s consideration of legally defining “sex” based only on “immutable biological traits identifiable by or before birth” could wipe out the impressive gains made by the transgender community. (Turco’s op-ed was also published in the Valley News.)

Read article – Quotes Lisa Schwartz and Steven Woloshin, both professors of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, about findings released by Amarin Corp. for Vascepa, its preventive medicine for people at risk of heart disease. Amarin Corp claimed that Vascepa caused a 25 percent relative risk reduction for deaths related to heart attacks, strokes, and other conditions, but the particulars of the scientific study on which this claim was based remain a mystery.

Read article – Article quotes Lisa Schwartz, professor of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, about cancer screenings. It is a popular notion that frequent cancer screenings saves lives, but is there a downside to these tests? A team of researchers believe that the impact of cancer screening tests is not as beneficial as previously thought and in some cases can result in an over diagnosis of cancer. “If the chance of dying from a cancer is small to begin with, there isn’t that much risk to reduce,” Schwartz said. “So the effect of even a good screening test has to be small in absolute terms.”

Read article – Patients with sclerosis assigned to a fibroproliferative subset, who are typically unresponsive to immunosuppressive drugs such as abatacept or mycophenolate mofetil, benefited from hematopoietic stem cell transplantation, according to Michael Whitfield, PhD, of the Geisel School of Medicine at Dartmouth.